Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Europe Anticoagulant Reversal Drugs Market By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By Product Type (Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published Date : 14-Jun-2021

Pages: 74

Formats: PDF

The Europe Anticoagulant Reversal Drugs Market would witness market growth of 12.9% CAGR during the forecast period (2021-2027). Anticoagulant drugs are widely used for treatment and ¬prevention of thromboembolic problems. So, these patients do require anticoagulant reversal drugs for management of bleeding. While taking anticoagulation reversal, it is must to consider aspects such as the anticoagulant type, dose, and the timings of the last dose.

Undesirable bleeding is one of the major concerns and complications of anticoagulant therapy. The possibility of bleeding differs from person to person as well as with the type of anticoagulant agent being taken. The anticoagulant reversal drugs market has been flourished in recent years due to the aspects such as the launch and approval of novel therapies and the increasing occurrence of bleeding disorders. The incidence of indications for anticoagulant therapy is also increasing which is contributing to the demand for the anticoagulant reversal drugs.

According to the British Heart Foundation Centre, 2018 report, it was estimated that there were around 7.4 million people suffering from heart and circulatory diseases in the United Kingdom. Also, 43,000 people below the age of 75 died of heart and circulatory diseases in the United Kingdom each year. The Human medicines committee of European Medical Association has approved the conditional marketing authorization of Ondexxya (andexanet alfa) in the European Union. This medicine used as an antidote for adult patients who need to have a reversal of anticoagulant (clot-preventing) in the emergency situation of life-threatening or uncontrolled bleeding. The increasing prevalence of atrial fibrillation (AFiB) and rising risk of stroke in the UK are the major driving factors for the anticoagulant reversal drug market in Europe. Though, the market is likely to experience slow growth in coming years due to the high cost of anticoagulant reversal drugs.

The Germany market dominated the Europe Prothrombin Complex Concentrates Market by Country in 2020, thereby, achieving a market value of $16.3 million by 2027. The UK market is showcasing a CAGR of 12.5% during (2021-2027). Additionally, The France market is anticipated to witness a CAGR of 14.9% during (2021-2027).

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Anticoagulant Reversal Drugs Market Size will Hit $1.6 Billion by 2027, at a CAGR of 13.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy’s Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Product Type

  • Idarucizumab
  • Andexanet Alfa
  • Prothrombin Complex Concentrates
  • Phytonadione
  • Protamine
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Boehringer Ingelheim International GmbH
  • CSL Limited
  • Bausch Health Companies, Inc.
  • Octapharma AG
  • Pfizer, Inc.
  • Fresenius SE & Co. KGaA
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • Dr. Reddy’s Laboratories Ltd.
  • AMAG Pharmaceuticals, Inc. (Covis Pharma)
  • Alps Pharmaceutical Ind. Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Anticoagulant Reversal Drugs Market, by Distribution Channel
1.4.2 Europe Anticoagulant Reversal Drugs Market, by Product Type
1.4.3 Europe Anticoagulant Reversal Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Opportunities:

Chapter 3. Europe Anticoagulant Reversal Drugs Market by Distribution Channel
3.1 Europe Hospital Pharmacy Market by Country
3.2 Europe Retail Pharmacy Market by Country
3.3 Europe Online Pharmacy Market by Country

Chapter 4. Europe Anticoagulant Reversal Drugs Market by Product Type
4.1 Europe Idarucizumab Market by Country
4.2 Europe Andexanet Alfa Market by Country
4.3 Europe Prothrombin Complex Concentrates Market by Country
4.4 Europe Phytonadione Market by Country
4.5 Europe Other Product Type Market by Country

Chapter 5. Europe Anticoagulant Reversal Drugs Market by Country
5.1 Germany Anticoagulant Reversal Drugs Market
5.1.1 Germany Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.2 Germany Anticoagulant Reversal Drugs Market by Product Type
5.2 UK Anticoagulant Reversal Drugs Market
5.2.1 UK Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.2 UK Anticoagulant Reversal Drugs Market by Product Type
5.3 France Anticoagulant Reversal Drugs Market
5.3.1 France Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.2 France Anticoagulant Reversal Drugs Market by Product Type
5.4 Russia Anticoagulant Reversal Drugs Market
5.4.1 Russia Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.2 Russia Anticoagulant Reversal Drugs Market by Product Type
5.5 Spain Anticoagulant Reversal Drugs Market
5.5.1 Spain Anticoagulant Reversal Drugs Market by Distribution Channel
5.5.2 Spain Anticoagulant Reversal Drugs Market by Product Type
5.6 Italy Anticoagulant Reversal Drugs Market
5.6.1 Italy Anticoagulant Reversal Drugs Market by Distribution Channel
5.6.2 Italy Anticoagulant Reversal Drugs Market by Product Type
5.7 Rest of Europe Anticoagulant Reversal Drugs Market
5.7.1 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel
5.7.2 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type

Chapter 6. Company Profiles
6.1 Boehringer Ingelheim International GmbH
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Octapharma AG
6.4.1 Company Overview
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Fresenius SE & Co. KGaA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Approvals:
6.8 Dr. Reddy’s Laboratories Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 AMAG Pharmaceuticals, Inc. (Covis Pharma)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Research & Development Expenses
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.9.4.2 Acquisition and Mergers:
6.10. Alps Pharmaceutical Ind. Co., Ltd.
6.10.1 Company Overview
TABLE 1 Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 2 Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 3 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 4 Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 5 Europe Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Hospital Pharmacy Market by Country, 2021-2027, USD Million
TABLE 7 Europe Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Retail Pharmacy Market by Country, 2021-2027, USD Million
TABLE 9 Europe Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Online Pharmacy Market by Country, 2021-2027, USD Million
TABLE 11 Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 12 Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 13 Europe Idarucizumab Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Idarucizumab Market by Country, 2021-2027, USD Million
TABLE 15 Europe Andexanet Alfa Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Andexanet Alfa Market by Country, 2021-2027, USD Million
TABLE 17 Europe Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
TABLE 19 Europe Phytonadione Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Phytonadione Market by Country, 2021-2027, USD Million
TABLE 21 Europe Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Other Product Type Market by Country, 2021-2027, USD Million
TABLE 23 Europe Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
TABLE 25 Germany Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 26 Germany Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 27 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 28 Germany Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 29 Germany Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 30 Germany Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 31 UK Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 32 UK Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 33 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 34 UK Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 35 UK Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 36 UK Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 37 France Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 38 France Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 39 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 France Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 41 France Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 42 France Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 43 Russia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 44 Russia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 45 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 46 Russia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 47 Russia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 48 Russia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 49 Spain Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 50 Spain Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 51 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 52 Spain Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 53 Spain Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 54 Spain Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 55 Italy Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 56 Italy Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 57 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 58 Italy Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 59 Italy Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 60 Italy Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 61 Rest of Europe Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 62 Rest of Europe Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 63 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 64 Rest of Europe Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 65 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 66 Rest of Europe Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 67 Key Information – Boehringer Ingelheim International GmbH
TABLE 68 key Information – CSL Limited
TABLE 69 key information – Bausch Health Companies, Inc.
TABLE 70 Key Information – Octapharma AG
TABLE 71 Key Information – Pfizer, Inc.
TABLE 72 key information – Fresenius SE & Co. KGaA
TABLE 73 key information – Alexion Pharmaceuticals, Inc.
TABLE 74 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 75 key information – AMAG Pharmaceuticals, Inc.
TABLE 76 key information – Alps Pharmaceutical Ind. Co., Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AMAG Pharmaceuticals, Inc.

Purchase Full Report of
Europe Anticoagulant Reversal Drugs Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL